Workflow to assign putative source to de novo peptide sequence
US20240153587A1 · Regeneron Pharmaceuticals, Inc. · priority 2021
| Patent | US20240153587A1 ↗ |
| Status | Pending |
| Priority date | 2021-03-11 |
| Filed | 2022-03-11 |
| Published | 2024-05-09 |
| Assignee | Regeneron Pharmaceuticals, Inc. |
| Also published as | AU2022235287A1, EP4305628A1, JP2024512391A, JP2025090717A, WO2022192739A1 |
Abstract
Methods and systems are described for optimizing search results through querying a plurality of databases according to false discovery, random hit rates are presented herein. Methods and systems adapted to assigning a putative source to a de novo peptide sequence and/or creating a workflow for performing said assignment are presented herein.
Why it is here
Regeneron: assigns a putative source organism or protein to a de novo peptide sequence by searching databases in order of random hit rate.
Inventors (4)
Lili Blumenberg, Kamil Cygan, Ankur Dhanik, Robert Salzler
An inventor links to an author page only where the same person is evident, never on a name alone.
Cited by (2 patent families, 2 organisations)
- Acer company: TWI921044B
- Honeywell International company: US20250363501A1
Every family, of any applicant, that cites this one, as Google Patents lists them; an assignee is given its English name.